ISLET Act

Ralph Norman

Republican · SC · Representative

Source: Congress.gov · FEC

• Don Bacon (R-NE-2)Original· 2026-03-19
• Tracey Mann (R-KS-1)· 2026-03-24
• Brandon Gill (R-TX-26)· 2026-04-21
• Nick LaLota (R-NY-1)· 2026-05-11

Referred to the House Committee on Energy and Commerce.

2026-03-19

Source: Congress.gov

The ISLET Act would establish or modify regulations related to islet cell transplantation, a medical procedure where insulin-producing cells are transplanted to help patients with type 1 diabetes manage their blood sugar levels. The bill likely aims to improve access to this treatment, streamline the approval process, or establish standards for how these transplants are conducted and covered by insurance. Patients with diabetes and healthcare providers would be the primary groups affected by these changes.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 8018 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 8018 To regulate human cadaveric islets for transplantation as organs. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 19, 2026 Mr. Norman (for himself and Mr. Bacon) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To regulate human cadaveric islets for transplantation as organs. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Increase Support for Life-saving Endocrine Transplantation Act'' or the ``ISLET Act''. SEC. 2. REGULATION OF HUMAN CADAVERIC ISLET TRANSPLANTS. (a) In General.--Section 374(d)(2) of the Public Health Service Act (42 U.S.C. 274b(d)(2)) is amended by striking ``pancreas,'' and inserting ``and pancreas, human cadaveric islets,''. (b) Clarification.--Notwithstanding any other provision of law, none of the following terms includes human cadaveric islets: (1) The term ``drug'', as defined in section 201(g) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)). (2) The term ``biological product'', as defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i)). (3) The term ``human cells, tissues, or cellular or tissue- based products (HCT/Ps)'', as defined in section 1271.3 of title 21, Code of Federal Regulations (or any successor regulations). (c) Regulations.-- (1) In general.--Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the ``Secretary'') shall update regulations promulgated under parts F, G, and H of title III of the Public Health Service Act (42 U.S.C. 262 et seq., 264 et seq., 273 et seq.) and the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.), and such other regulations as the Secretary determines appropriate, to carry out the amendment made by subsection (a). (2) Report.--Not later than 6 months after the date of enactment of this Act, the Secretary shall report to Congress on the progress made in updating regulations as required under paragraph (1). <all>

• HR9103To prohibit Federal research agencies and recipients of Federal research grants from using a prohibited diversity, equity, or inclusion practice with respect to Federal research grants, and for other purposes.
  Referred to Committee · 2026-06-02
• HR4463To amend the Catawba Indian Tribe of South Carolina Land Claims Settlement Act of 1993.
  Passed House · 2026-06-02
• HR3377To authorize the President to award the Medal of Honor to James Capers, Jr., for acts of valor as a member of the Marine Corps during the Vietnam War.
  Enacted into Law · 2026-03-26
• HR8118Election Infrastructure Integrity Act
  Referred to Committee · 2026-03-26